Skip to main content

An Open-Label, Dose Escalation, Efficacy, and Safety Study of CLR 131 in Children, Adolescents, and Young Adults with Select Solid Tumors, Lymphoma, and Malignant Brain Tumors (CLOVER-2)

Clinical Trial Grant
Duke Scholars

Administered By

Pediatrics, Hematology-Oncology

Awarded By

Cellectar Biosciences, Inc.

Start Date

December 29, 2021

End Date

December 31, 2023
 

Administered By

Pediatrics, Hematology-Oncology

Awarded By

Cellectar Biosciences, Inc.

Start Date

December 29, 2021

End Date

December 31, 2023